Indications for a contribution of paraoxonase type-1 to plasma high density lipoprotein levels in patients with familial hypercholesterolemia.

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia

October 2015

This is the publisher’s final pdf. The published article is copyrighted by the author(s) and co-publ...

Modulated serum acitivities and concentrations of paraoxonase in high density lipoprotein deficiency states

JAMES RW
BLATTER GARIN L
CALABRESI L
MICCOLI R
VON ECKARDSTEIN M
TILLY-KIESI M
TASKINEN MR
ASSMANN G
FRANCESCHINI G

January 1998

Paraoxonase is a high density lipoprotein (HDL) associated enzyme with a hypothesised role in the pr...

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on

COSTA, Lucio Guido
GIORDANO G.
FURLONG C. E.

January 2011

Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated enzyme displaying esterase and ...

Paraoxonase (PON1) is associated with familial combined hyperlipidemia.

Himbergen, T.M. van
Tits, L.J.H. van
Avest, E. ter
Roest, M.
Voorbij, H.A.
Graaf, J. de
Stalenhoef, A.F.H.

January 2008

Contains fulltext : 71837.pdf ( ) (Closed access)Familial combined hyperlipidemia ...

The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.

Himbergen, T.M. van
Tits, L.J.H. van
Voorbij, H.A.
Graaf, J. de
Stalenhoef, A.F.H.
Roest, M.

January 2005

Contains fulltext : 48180.pdf (publisher's version ) (Closed access)OBJECTIVES. St...

Research Article Serum Paraoxonase 1 Activity Is Associated with Fatty Acid Composition of High Density Lipoprotein

Seddigheh Asgary
Soheila Abdi

August 2016

Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia.

Himbergen, T.M. van
Tits, L.J.H. van
Hectors, M.P.C.
Graaf, J. de
Roest, M.
Stalenhoef, A.F.H.

January 2005

Item does not contain fulltextSerum paraoxonase-1 (PON1) is a high-density lipoprotein-associated en...

The lipoprotein lipase (Asn291->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia

Hoffer, M.J.V.
Bredie, S.J.H.
Boomsma, D.I.
Reymer, P.W.A.
Kastelein, J.J.P.
Knijff, P. de
Demacker, P.N.M.
Stalenhoef, A.F.H.
Havekes, L.M.
Frants, R.R.

January 1996

Contains fulltext : 23168.PDF (publisher's version ) (Open Access

Paraoxonase and cardiovascular disease: actions and interactions.

Himbergen, T.M. van

January 2006

Contains fulltext : 27457.pdf (publisher's version ) (Open Access)Paraoxonase type...

Paraoxonase (PON1) is associated with familial combined hyperlipidemia

van Himbergen, Thomas M
van Tits, Lambertus J H
Ter Avest, Ewoud
Roest, Mark
Voorbij, Hieronymus A M
de Graaf, Jacqueline
Stalenhoef, Anton F H

July 2008

Familial combined hyperlipidemia (FCH) is a common genetic lipid disorder of which the molecular bas...

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene

Muhammad Idrees (92773)
Abdul Rauf Siddiq (5552330)
Muhammad Ajmal (581123)
Muhammad Akram (438285)
Rana Rehan Khalid (5552327)
Alamdar Hussain (323649)
Raheel Qamar (348807)
Habib Bokhari (606503)

July 2018

Abstract Paraoxonase 1 (PON1) is a serum enzyme associated with high density lipoprotein (HDL) regul...

Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers.

Himbergen, T.M. van
Roest, M.
Waart, F. de
Graaf, J. de
Voorbij, H.A.
Tits, L.J.H. van
Stalenhoef, A.F.H.

January 2004

Contains fulltext : 59069.pdf (publisher's version ) (Closed access)Paraoxonase (P...

Familial combined hyperlipidemia: metabolic and genetic aspects

Bredie, S.J.H.

January 1997

Contains fulltext : mmubn000001_255044194.pdf (publisher's version ) (Open Access)...

High‐density lipoprotein‐associated paraoxonase 1: a possible prognostic biomarker for heart failure?

Rom, Oren
Aviram, Michael

June 2017

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/137330/1/ejhf817_am.pdfhttps://deepblu...

Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states

R. James
M. Garin
L. Calabresi
R. Miccoli
A. von Eckardstein
M. Tilly-Kiesi
M. Taskinen
G. Assmann
G. Franceschini

January 1998

Paraoxonase is a high density lipoprotein (HDL) associated enzyme with a hypothesised role in the pr...

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia

October 2015

This is the publisher’s final pdf. The published article is copyrighted by the author(s) and co-publ...

Modulated serum acitivities and concentrations of paraoxonase in high density lipoprotein deficiency states

JAMES RW
BLATTER GARIN L
CALABRESI L
MICCOLI R
VON ECKARDSTEIN M
TILLY-KIESI M
TASKINEN MR
ASSMANN G
FRANCESCHINI G

January 1998

Paraoxonase is a high density lipoprotein (HDL) associated enzyme with a hypothesised role in the pr...

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on

COSTA, Lucio Guido
GIORDANO G.
FURLONG C. E.

January 2011

Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated enzyme displaying esterase and ...

Paraoxonase (PON1) is associated with familial combined hyperlipidemia.

Himbergen, T.M. van
Tits, L.J.H. van
Avest, E. ter
Roest, M.
Voorbij, H.A.
Graaf, J. de
Stalenhoef, A.F.H.

January 2008

Contains fulltext : 71837.pdf ( ) (Closed access)Familial combined hyperlipidemia ...

The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.

Himbergen, T.M. van
Tits, L.J.H. van
Voorbij, H.A.
Graaf, J. de
Stalenhoef, A.F.H.
Roest, M.

January 2005

Contains fulltext : 48180.pdf (publisher's version ) (Closed access)OBJECTIVES. St...

Research Article Serum Paraoxonase 1 Activity Is Associated with Fatty Acid Composition of High Density Lipoprotein

Seddigheh Asgary
Soheila Abdi

August 2016

Paraoxonase-1 and linoleic acid oxidation in familial hypercholesterolemia.

Himbergen, T.M. van
Tits, L.J.H. van
Hectors, M.P.C.
Graaf, J. de
Roest, M.
Stalenhoef, A.F.H.

January 2005

Item does not contain fulltextSerum paraoxonase-1 (PON1) is a high-density lipoprotein-associated en...

The lipoprotein lipase (Asn291->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia

Hoffer, M.J.V.
Bredie, S.J.H.
Boomsma, D.I.
Reymer, P.W.A.
Kastelein, J.J.P.
Knijff, P. de
Demacker, P.N.M.
Stalenhoef, A.F.H.
Havekes, L.M.
Frants, R.R.

January 1996

Contains fulltext : 23168.PDF (publisher's version ) (Open Access

Paraoxonase and cardiovascular disease: actions and interactions.

Himbergen, T.M. van

January 2006

Contains fulltext : 27457.pdf (publisher's version ) (Open Access)Paraoxonase type...

Paraoxonase (PON1) is associated with familial combined hyperlipidemia

van Himbergen, Thomas M
van Tits, Lambertus J H
Ter Avest, Ewoud
Roest, Mark
Voorbij, Hieronymus A M
de Graaf, Jacqueline
Stalenhoef, Anton F H

July 2008

Familial combined hyperlipidemia (FCH) is a common genetic lipid disorder of which the molecular bas...

Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene

Muhammad Idrees (92773)
Abdul Rauf Siddiq (5552330)
Muhammad Ajmal (581123)
Muhammad Akram (438285)
Rana Rehan Khalid (5552327)
Alamdar Hussain (323649)
Raheel Qamar (348807)
Habib Bokhari (606503)

July 2018

Abstract Paraoxonase 1 (PON1) is a serum enzyme associated with high density lipoprotein (HDL) regul...

Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers.

Himbergen, T.M. van
Roest, M.
Waart, F. de
Graaf, J. de
Voorbij, H.A.
Tits, L.J.H. van
Stalenhoef, A.F.H.

January 2004

Contains fulltext : 59069.pdf (publisher's version ) (Closed access)Paraoxonase (P...

Familial combined hyperlipidemia: metabolic and genetic aspects

Bredie, S.J.H.

January 1997

Contains fulltext : mmubn000001_255044194.pdf (publisher's version ) (Open Access)...

High‐density lipoprotein‐associated paraoxonase 1: a possible prognostic biomarker for heart failure?

Rom, Oren
Aviram, Michael

June 2017

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/137330/1/ejhf817_am.pdfhttps://deepblu...

Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states

R. James
M. Garin
L. Calabresi
R. Miccoli
A. von Eckardstein
M. Tilly-Kiesi
M. Taskinen
G. Assmann
G. Franceschini

January 1998

Paraoxonase is a high density lipoprotein (HDL) associated enzyme with a hypothesised role in the pr...

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia

October 2015

This is the publisher’s final pdf. The published article is copyrighted by the author(s) and co-publ...

Modulated serum acitivities and concentrations of paraoxonase in high density lipoprotein deficiency states

JAMES RW
BLATTER GARIN L
CALABRESI L
MICCOLI R
VON ECKARDSTEIN M
TILLY-KIESI M
TASKINEN MR
ASSMANN G
FRANCESCHINI G

January 1998

Paraoxonase is a high density lipoprotein (HDL) associated enzyme with a hypothesised role in the pr...

Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on

COSTA, Lucio Guido
GIORDANO G.
FURLONG C. E.

January 2011

Paraoxonase 1 (PON1) is a high density lipoprotein (HDL)-associated enzyme displaying esterase and ...

Indications for a contribution of paraoxonase type-1 to plasma high density lipoprotein levels in patients with familial hypercholesterolemia.

Abstract

Extracted data

Indications for a contribution of paraoxonase type-1 to plasma high density lipoprotein levels in patients with familial hypercholesterolemia.

Abstract

Extracted data

Related items

Related items